KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Return on Invested Capital (2021 - 2023)

Cardlytics filings provide 3 years of Return on Invested Capital readings, the most recent being 0.02% for Q1 2023.

  • Quarterly Return on Invested Capital fell 2.0% to 0.02% in Q1 2023 from the year-ago period, while the trailing twelve-month figure was 0.02% through Mar 2023, down 2.0% year-over-year, with the annual reading at 0.01% for FY2022, 1.0% down from the prior year.
  • Return on Invested Capital hit 0.02% in Q1 2023 for Cardlytics, down from 0.01% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.0% in Q1 2022 and bottomed at 0.02% in Q1 2023.
  • Average Return on Invested Capital over 3 years is 0.01%, with a median of 0.0% recorded in 2021.
  • The largest annual shift saw Return on Invested Capital dropped -1bps in 2022 before it dropped -2bps in 2023.
  • Cardlytics' Return on Invested Capital stood at 0.0% in 2021, then tumbled by -680bps to 0.01% in 2022, then plummeted by -88bps to 0.02% in 2023.
  • Per Business Quant, the three most recent readings for CDLX's Return on Invested Capital are 0.02% (Q1 2023), 0.01% (Q4 2022), and 0.0% (Q3 2022).